Acute autonomic sensory and motor neuropathy (AASMN) is characterized by prominent dysautonomia with somatic sensory and motor impartment. Prominent dysautonomia is observed during the early phase of AASMN. We herein describe a case of AASMN that involved prolonged autonomic failure and disturbance of sensation despite a rapid recovery from motor weakness. The early and delayed heart-to-mediastinum ratios on 123 I-meta-iodobenzylguanidine myocardial scintigraphy were decreased and improved within seven months. However, orthostatic hypotension was prolonged. These results suggest a differential improvement in the cardiac and vasomotor sympathetic functions.
Introduction
The concomitant manifestation of sensory and motor impairment has been reported in patients with autonomic neuropathy with a monophasic clinical course similar to Guillain-Barré syndrome (GBS) (1) (2) (3) (4) (5) (6) . Some of these patients were reported to have acute autonomic sensory and motor neuropathy (AASMN) (3) (4) (5) (6) . Although the degree, timing and prognosis of sensory and motor deficits were variable in these reported cases, severe autonomic failure affecting both the sympathetic and parasympathetic functions in the initial phase of the disease was the common feature in these patients. 123 I-meta-iodobenzylguanidine ( 123 I-MIBG) myocardial scintigraphy has been used to examine the function of cardiac sympathetic nerves, particularly the postganglionic fibers (7, 8) . The beneficial aspects and therapeutic efficacy of 123 I-MIBG myocardial scintigraphy in assessing sympathetic dysfunction have not been described in patients with this type of neuropathy.
In this report, we describe the clinical features of a case of AASMN with prolonged autonomic failure and disturbance of sensation despite a rapid recovery from motor weakness. There were differential improvements in the 123 I-MIBG myocardial scintigraphy abnormalities and orthostatic hypotension. The control values are based on a previously published reports (9, 10).
Controls (mean±SD)
and oral cavity mucous membranes were dry. He exhibited pupil dilation to 6 mm in diameter on both sides. The pupillary light reflex was slow and the corneal reflex was reduced. His ocular motion was normal. He had moderate bilateral facial palsy and dysarthria. He exhibited mild muscular weakness in the proximal limbs. Profound ataxia in the extremities was observed in a finger-to-nose test and a heelto-knee test. Deep tendon reflexes were absent in the upper and lower extremities. The plantar responses were flexor on both sides. The sensation of pain and light touch were moderately decreased in the face and trunk and severely diminished in the upper and lower distal extremities. The sensations of vibration and position were also severely decreased in the distal limbs. There was no apparent laterality of sensory disturbance. Pseudoathetosis was observed in the upper limbs, and the Romberg test was positive in the sitting position.
Blood cell counts and a urinalysis showed no appreciable abnormalities. The patient's blood chemistry demonstrated elevated levels of creatine kinase (CK) and C-reactive protein (CRP) (CK: 393 IU, CRP: 4.05 mg/dL). Findings suggestive of syndrome of inappropriate antidiuretic hormone secretion (SIADH) were observed, including hyponatremia, low plasma osmolality and a normal renal function without hormonal abnormalities (serum Na: 124 mEq/L, plasma osmolality: 251 mOsm/L, ADH: 1.6 pg/mL, serum cortisol: 17.8 μg/dL). The urinalysis results were also consistent with SIADH (urine osmolality: 578 mOsm/L; urine Na: 150 mEq/L). A serum autoantibody test showed slightly elevated levels of anti-SS-A antibodies and anti-muscular acetylcholine receptor antibodies (anti-SS-A antibodies: 11.9, normal: <10.0; anti-muscular acetylcholine receptor antibodies: 0.3 nmol/L, normal: <0.2 nmol/L). However, the patient had no abnormalities of anti-SS-B antibodies. He was negative for anti-ganglioside antibodies and anti-ganglionic acetylcholine receptor antibodies. A stool culture detected only Escherichia coli. A cerebrospinal fluid examination revealed a protein level of 52 mg/dL, with no abnormalities in the cell count. Cranial and spinal magnetic resonance imaging performed on admission revealed no abnormalities.
The results of the nerve conduction studies, measured using a standard method with surface electrodes for stimulation and recording (9, 10) , are shown in Table 1 . The nerve conduction study findings were within the normal range, except for a reduced occurrence of F-waves in the median nerve at the time of admission. However, in follow-up studies performed one month later, the motor nerve conduction velocities were slightly decreased in the median, ulnar and tibial nerves (45.6 m/s, 43.2 m/s and 37.6 m/s, respectively), while the sensory nerve action potentials were very low in the median nerve (0.6 μV) and not evoked in the ulnar or sural nerves. A sural nerve biopsy revealed severe loss of both myelinated and unmyelinated fibers on light and electron microscopic observations. The densities of large myelinated fibers, small myelinated fibers and unmyelinated fibers were 815, 2,543 and 744 fibers/mm 2 , respectively (the control values of five patients aged 36.8±13.7 years: 3,337±243, 5,271±408 and 29,201±3,925 fibers/mm 2 , respectively). No clusters of nerve fibers suggestive of axonal regeneration were found.
The results of the clinical autonomic nerve function tests are shown in Table 2 . A head-up tilt test showed a 27-mmHg drop in systolic blood pressure (this test was conducted at a 60°tilt angle with the patient's legs on the horizontal level due to the occurrence of syncope). The patient's basal plasma noradrenaline level was very low (8.0 pg/mL, normal: 100-450 pg/mL) and his head-up tilt test noradrenaline level was 12 pg/mL. A noradrenaline infusion test caused a 47-mmHg systolic blood pressure increase during low-concentration (0.3 μg/min) intravenous infusion for three minutes, indicating the presence of denervation hypersensitivity due to sympathetic dysfunction (11) . A miotic response was observed with 0.1% pilocarpine eye drops and mydriasis was observed with 1.0% phenylephrine eye drops, indicating the presence of denervation hypersensitivity due to both peripheral sympathetic and parasympathetic dysfunction (12) . On electrocardiogram, the coefficient of variation of the R-R intervals (CVR-R) measured at rest was normal. The early and delayed heart-to-mediastinum (H/M) ratio was decreased on 123 I-MIBG myocardial scintigraphy [early: 1.37, normal: 1.92-2.77 (8); delay: 1.37, normal: 1.93-2.55 (8)] (Figure) . The patient had urinary retention and his residual urinary volume was 930 mL.
Intravenous immunoglobulin (IVIg) was administered following a diagnosis of AASMN on the day of admission. After IVIg treatment, the patient's muscular weakness improved over the following ten days. The SIADH improved approximately three weeks after admission. Although the di- The normal values are based on previously published reports (8, 11, 12) . A diagnosis of orthostatic hypotension in the head-up tilt test was made when the patient showed a reduction in systolic blood pressure of at least 20 mmHg. A diagnosis of hypersensitivity in the NA infusion test was made when the infusions produced a rise of systolic blood pressure greater than 20 mmHg. The pupillary responses were determined following application of cholinergic and adrenergic agents. The coefficient of variation of the R-R intervals on electrocardiography measured at rest under normal breathing. The normal value was mean: 3.21%, lower limit: 1.66%. arrhea continued for two weeks after admission, the patient suffered from a sustained loss of appetite. Due to early satiety, he did not achieve an adequate oral intake for five months, and his weight fell to 39.8 kg. His abdomen was tested repeatedly using X-ray and CT; however, no significant abnormalities were identified other than reduced peristalsis. The patient experienced a long-lasting bout of coughing without pneumonia or bronchitis. He was treated with dimemorfan phosphate; however, his coughing continued for five months after admission. At that time, he could not stand or walk due to orthostatic hypotension and sensory ataxia. The sensory impairment did not change significantly, even three years after admission. The abnormalities observed on 123 I-MIBG myocardial scintigraphy improved (Figure) . The early/delayed H/M ratio changed from 1.63/1.52 at four months after admission to 1.94/2.02 seven months after admission. The patient's autonomic nerve function tests continued to show some abnormalities five months after admission ( Table 2 ). The miotic response and mydriasis observed using 0.1% pilocarpine and 1.0% phenylephrine, respectively, also disappeared. However, the head-up tilt test continued to show a significant drop in systolic pressure despite the administration of symptomatic treatment with fludrocortisone acetate, amezinium metilsulfate and midodrine hydrochloride. Blood pressure elevation continued to be observed on the noradrenaline infusion test. The patient's urinary disturbance was also prolonged and he therefore required intermittent urethral catheterization. Although the severity of orthostatic hypotension did not change significantly, the patient was able to sit for short periods without loss of consciousness three years later. Additionally, a marked improvement in dysuria was observed, and the patient exhibited no residual urine at that time.
Discussion
In this case, rapidly progressive autonomic failure and sensory disturbance occurred six days after the onset of diarrhea, which was considered to be an antecedent infection. A mild to moderate degree of motor disturbance appeared later. In this patient, dysautonomia was observed in both the peripheral sympathetic and parasympathetic nervous systems. From the viewpoint of autonomic neuropathy with a monophasic clinical course similar to GBS, studies have described at least three major groups based on concomitant sensory motor involvement (13, 14) : (1) pure autonomic neuropathy (15) (16) (17) , (2) acute autonomic and sensory neuropathy (13, 18, 19) and (3) AASMN (3-6) . The nosological entity of AASMN should be considered carefully because autonomic dysfunction has been frequently reported in patients with GBS (14, 20-22) . One may argue that AASMN 
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should be considered a form of GBS with prominent autonomic dysfunction. Indeed, so far, the reported cases of AASMN seem to be heterogeneous from the perspective of the timing of appearance, severity, prognosis of weakness and pathology. Neuronal cell loss in the dorsal root ganglia was shown in one autopsy case that involved profound dysautonomia as the initial manifestation and the development of weakness several days later (23) . This case report suggests that ganglionopathy participates in the pathogenesis of typical cases of AASMN (14) . Autonomic neuropathies may be primary or occur secondary to underlying diseases such as paraneoplastic syndrome, connective tissue diseases and celiac disease (14) . Although the level of SS-A antibodies was slightly increased in our case, tests for anti-SS-B antibodies were negative. The autonomic impairment seen in cases of Sjögren syndrome is usually chronic, different from that observed in our case (14) . Although the patient complained of dry eyes and dry mouth, these symptoms can also be associated with autonomic failure. In our case, autonomic failure was the prominent feature throughout the course of the disease, and the prognosis of the motor deficits was favorable. Therefore, treating autonomic failure is more important than treating motor impairment, and our patient might be more appropriately included in the spectrum of autonomic neuropathy with a monophasic clinical course (14) . Furthermore, the prognosis of autonomic and sensory deficits was poor, supporting the view that ganglionopathy participated in the pathogenesis. In this context, we report the present patient as having AASMN. However, the continuum between AASMN and acute autonomic and sensory neuropathy should be explicitly determined. Motor dysfunctions reported as acute autonomic and sensory neuropathy may occur primarily or secondarily to disuse or abnormalities of neighboring autonomic and sensory nerves in the nerve trunk (14) . Indeed, some patients diagnosed with acute autonomic and sensory neuropathy are also reported to have motor dysfunction (24) (25) (26) . Taking the significant residual neurological deficits into consideration, ganglionopathy may have participated in the pathogenesis of neuropathy in this case. However, slight slowing of the MCV was concomitantly observed. This finding indicates that motor nerve damage other than damage to the sensory and autonomic neurons may concomitantly be present in our case. This issue should be clarified in future studies. In this case, the autonomic failure was caused by injury to the postganglionic neurons. The results of a noradrenaline infusion test and 123 I-MIBG myocardial scintigraphy established the existence of postganglionic sympathetic nerve injuries (7, 8, 11) . A noradrenaline infusion test indicated the presence of denervation hypersensitivity and vasomotor sympathetic dysfunction (11) , while the 123 I-MIBG myocardial scintigraphy abnormalities indicated the presence of cardiac sympathetic dysfunction (7, 8) . The abnormalities observed on 123 I-MIBG myocardial scintigraphy improved after seven months. However, orthostatic hypotension and hypersensitivity to the noradrenaline infusion test were prolonged. Although other tests assessing cardiac and vasomotor sympathetic dysfunction were not performed, these results may indicate differential improvements in the cardiac and vasomotor sympathetic functions. A similar phenomenon was reported in a case of acute autonomic neuropathy without sensory or motor involvement (27) . In previous reports of autonomic neuropathy with somatic involvement, the patients were rarely evaluated with 123 I-MIBG myocardial scintigraphy. Similar to our case, some patients with GBS showed improvements in the H/M ratio (28, 29) ; however, the associated dysautonomia was not well described. Therefore, it is necessary for 123 I-MIBG myocardial scintigraphy findings to be reported in similar cases. Because recovery of autonomic dysfunction in the currently reported cases of AASMN is not favorable compared with that observed for motor deficits (2, 3, 6), using objective indices that indicate recovery from the early period of disease is important for determining the therapeutic efficacy in individual patients. 123 I-MIBG myocardial scintigraphy may be suitable for such a purpose in patients with autonomic neuropathies. As for our case, it is difficult to determine whether the improvement was attributable to the treatment or that it simply reflected the natural course of the disease. A large scale study is therefore needed to clarify this issue.
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